Inhibition of PDE10A by either genetic silencing or pharmacological inhibition was also reported to decrease cancer cell growth through increased cGMP/PKG signaling and subsequent decreased β-catenin-dependent TCF/LEF transcriptional activity in colon and lung cancer cells [26, 27]. The gene discussed is PDE10A; the disease is lung carcinoma.